Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Emery and Hayflick continued the debate on integrating genetic
medicine into primary care.1 We agree that primary care
will identify people at genetic risk and help manage known risk not
only for the patient but also for other family members. Emery and
Hayflick define clear roles for primary care practitioners and draw on
qualitative studies to claim that they are accepted roles of primary care.
But they cite only one study and overlook those that challenge their
position
for example, Kumar and Gantley, and Elwyn et al.
2 3
In the former general practitioners knowledgeable about genetic advances resisted taking on many of the tasks Emery and
Hayflick identify for general practitioners because of ethical dilemmas
associated with the therapeutic gap in the context of common cancers.
In the latter, practitioners working in deprived communities questioned
the validity of unearthing genetic risk issues when other more
practical and demand led